⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXEL News
Exelixis Inc
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO
prnewswire.com
EXEL
SNY
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
globenewswire.com
ONCY
AGEN
CRDF
EXEL
GILD
Strategic Pharma Collaborations Propel RCC Market Growth
globenewswire.com
MRK
AZN
PFE
EXEL
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
businesswire.com
EXEL
Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034) Driven by Increasing Screening Rates and Novel Drug Approvals | DelveInsight
prnewswire.com
AGN
NOVN
EXEL
ABBV
BMY
EISAY
TKPY
MRK
Circle Pharma Appoints Anne E. Borgman, M.D., as Chief Medical Officer
businesswire.com
JAZZ
EXEL
ABT
NCUX
CUR
SUTB
Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pipeline | DelveInsight
prnewswire.com
EXEL
IPN
Prostate Cancer Drugs Market to Reach USD 28.10 Billion by 2033 | According to DataM Intelligence
prnewswire.com
BIIB
MRK
JNJ
PFE
AZN
BMY
GILD
EXEL
RDVY
CRIS
VRTX
INCY
ABBV
LULU
VIR
FGEN
HALD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
accessnewswire.com
EXEL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
accessnewswire.com
EXEL